Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company engaged in the discovery and development of new drugs for the treatment of Alzheimer’s and other neurological diseases and cancer.
Past: Former Co-Founder of financial advisory firm, clients in the Americas, Europe & Asia | Present: Ultra Aggressive Beta Select Fund | Near Future: Bulge Bracket Market Maker | Stock Market Rule 1: Never bet against my house. Never.
Neurotrope (NTRP) is a biopharmaceutical and diagnostics company principally focused on developing two product platforms, a diagnostic test for Alzheimerâ€™s Disease and a drug candidate called bryostatin for the treatment of Alzheimerâ€™s Disease.
Prism Digital was created for public companies by seasoned investors. We brought together a team of innovators from Wall Street to Madison Avenue that decided to change the agency
model to foster and inspire innovation.